Apellis Pharmaceuticals
APLS
$40.56
Share price
-0.12%
Change (1 day)
-53.36%
Change (1 year)
Categories
Apellis Pharmaceuticals (APLS) - Total assets
Total assets on the balance sheet as of March 2024 : $0.83 B
According to Apellis Pharmaceuticals's latest financial reports the company's total assets are $0.83 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Apellis Pharmaceuticals - Total assets on balance sheet (from 2014 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.78 B | 3.75% |
| 2022-12-31 | $0.76 B | -13.78% |
| 2021-12-31 | $0.88 B | -8.2% |
| 2020-12-31 | $0.96 B | 146.78% |
| 2019-12-31 | $0.38 B | 91.24% |
| 2018-12-31 | $0.20 B | 11.75% |
| 2017-12-31 | $0.18 B | 563.91% |
| 2016-12-31 | $27.43 M | -28.14% |
| 2015-12-31 | $38.17 M | 166.86% |
| 2014-12-31 | $14.3 M | 175.15% |
| 2013-12-31 | $5.19 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.35 B | -57.83% | 🇺🇸 USA |